Registered Trials

• ChiCTR2000040153, NCT04646590

  Phase 3

  China, Ecuador, Indonesia, Pakistan, Uzbekistan

  Total Enrollment: 29,000

  Official Trial Registration:

  • ChiCTR2000040153(Opens in new tab/window)
  • NCT04646590(Opens in new tab/window)

• NCT04466085

  Phase 2

  China

  Total Enrollment: 900

  Official Trial Registration:

  • NCT04466085(Opens in new tab/window)

• NCT04813562

  Phase 2

  China

  Total Enrollment: 480

  Official Trial Registration:

  • NCT04813562(Opens in new tab/window)

• NCT04961359

  Phase 1

  China

  Total Enrollment: 75

  Official Trial Registration:

  • NCT04961359(Opens in new tab/window)

• NCT04445194

  Phase 1

  China

  Total Enrollment: 50

  Official Trial Registration:

  • NCT04445194(Opens in new tab/window)

• NCT04636333

  Phase 1

  China

  Total Enrollment: 216

  Official Trial Registration:

  • NCT04636333(Opens in new tab/window)

• NCT04550351, ChiCTR2000035691

  Phase 1

  China

  Total Enrollment: 50

  Official Trial Registration:

  • NCT04550351(Opens in new tab/window)
  • ChiCTR2000035691(Opens in new tab/window)